Assessment of the Neurovascular Microcirculatory Response in Diabetes Type 1 Patients

This study aims to see whether or not the diabetes 1 patients have a neurovascular microcirculatory dysfunction using various microvascular tests which have been previously validated.

Microvascular responses will be assessed by Laser Speckle Contrast Imaging and expressed in Laser Speckle Perfusion Units (LSPU).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Diabetes Mellitus Type 1 Autoimmune Diseases Diabetes Mellitus Diabetes Mellitus, Type 1 Endocrine System Diseases Glucose Metabolism Disorders Immune System Diseases Metabolic Diseases Nutritional and Metabolic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University Hospital

Angers, 49000, France

About this study

The investigators will compare microvascular responses between diabetes type 1 patients with matched control-subjects.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Diabetes type 1 patients
Matched control-subjects

Exclusion criteria

Patients or subjects with anti-inflammatory drugs

Treatment and study plan

Microvascular assessment

Other

Microvascular assessment

Primary outcomes

Neurovascular microcirculatory response

Time frame: one day

Neurovascular response will be assessed by laser speckle contrast imaging using various microvascular tests such as deionized water iontophoresis, local heating test. Results will be explained in Laser Speckle Perfusion Units (LSPU)

Sponsors and collaborators

Lead sponsor

University Hospital, Angers

Other Gov

Registry information

Official study title

Assessment of the Neurovascular Microcirculatory Response in Diabetes Type 1

Acronym: NEURODIAB1

Important dates

Study start: 2012
Primary completion: 2015
Study completion: 2015
First posted: Sep 2, 2015
Registry last updated: Feb 12, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed